TPMT, COMT and ACYP2 genetic variants in paediatric cancer patients with cisplatin-induced ototoxicity.

about

TPMT, COMT and ACYP2 genetic variants in paediatric cancer patients with cisplatin-induced ototoxicity.

Item

http://www.wikidata.org/entity/Q38818727

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

TPMT, COMT and ACYP2 genetic v ...... cisplatin-induced ototoxicity.

@en

type

Item

label

TPMT, COMT and ACYP2 genetic v ...... cisplatin-induced ototoxicity.

@en

prefLabel

TPMT, COMT and ACYP2 genetic v ...... cisplatin-induced ototoxicity.

@en

P1476

TPMT, COMT and ACYP2 genetic v ...... cisplatin-induced ototoxicity

@en

P2093

Andrea L Jorgensen

http://www.w3.org/2001/XMLSchema#string

Barry Pizer

http://www.w3.org/2001/XMLSchema#string

Christopher Barton

http://www.w3.org/2001/XMLSchema#string

David Walker

http://www.w3.org/2001/XMLSchema#string

Harish Vyas

http://www.w3.org/2001/XMLSchema#string

Jieying Eunice Zhang

http://www.w3.org/2001/XMLSchema#string

Laurence McEvoy

http://www.w3.org/2001/XMLSchema#string

Penelope Brock

http://www.w3.org/2001/XMLSchema#string

Peng Yin

http://www.w3.org/2001/XMLSchema#string

Signe Thiesen

http://www.w3.org/2001/XMLSchema#string

P2860

Platinum-induced ototoxicity in children: a consensus review on mechanisms, predisposition, and protection, including a new International Society of Pediatric Oncology Boston ototoxicity scale.

Measuring inconsistency in meta-analyses

Quantifying heterogeneity in a meta-analysis

Genetic variants in TPMT and COMT are associated with hearing loss in children receiving cisplatin chemotherapy

Risk factors for cisplatin-associated ototoxicity in pediatric oncology patients.

Replication of TPMT and ABCC3 genetic variants highly associated with cisplatin-induced hearing loss in children.

Pharmacogenetics of warfarin in a paediatric population: time in therapeutic range, initial and stable dosing and adverse effects.

Influence of genetic variants in TPMT and COMT associated with cisplatin induced hearing loss in patients with cancer: two new cohorts and a meta-analysis reveal significant heterogeneity between cohorts.

Common variants in ACYP2 influence susceptibility to cisplatin-induced hearing loss

Ototoxicity of cisplatinum in children and adolescents.

P304

213-222

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

meta-analysis

P356

10.1097/FPC.0000000000000281

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

P577

2017-06-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28445188

http://www.w3.org/2001/XMLSchema#string

P932

5432027

http://www.w3.org/2001/XMLSchema#string